针对华裔和韩裔美国人的针对亚洲文化的肺健康干预研究的随机对照试验:研究方案。

IF 1.9 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Sun S. Kim , Manan M. Nayak , Ling Shi , Hua Chen , Sohyon Pak , Joosun Shin , Chi-Fu Yang , Fang Lei , Mary E. Cooley
{"title":"针对华裔和韩裔美国人的针对亚洲文化的肺健康干预研究的随机对照试验:研究方案。","authors":"Sun S. Kim ,&nbsp;Manan M. Nayak ,&nbsp;Ling Shi ,&nbsp;Hua Chen ,&nbsp;Sohyon Pak ,&nbsp;Joosun Shin ,&nbsp;Chi-Fu Yang ,&nbsp;Fang Lei ,&nbsp;Mary E. Cooley","doi":"10.1016/j.cct.2025.108102","DOIUrl":null,"url":null,"abstract":"<div><div>Asian Americans are less likely to receive smoking cessation advice and more likely to be diagnosed with lung cancer at a distant stage of the disease than the general U.S. population. The primary outcomes of this study are the uptake of a lung cancer screening (LCS) test and biochemically verified smoking cessation abstinence 6 months after baseline assessment among 128 Asian Americans. The secondary outcomes include self-reported 7-day point prevalence abstinence at 1, 3, and 6 months. Participants will be randomized to either an experimental or a control group. The experimental group will receive a deep-level Asian culturally tailored lung health (ACT) intervention consisting of eight smoking cessation counseling sessions, education about the LCS test, and family coaching. Participants in the control group will receive a surface-level ACT intervention that includes six smoking cessation counseling sessions. Both groups will have the option of having counseling sessions via either video or telephone calls, depending on their preference. Counselors in both groups will be matched with participants based on ethnicity and language. Additionally, all participants irrespective of group allocation will receive combined nicotine replacement therapy (NRT) products and educational materials about LCS decision-aids and NRT products. The deep-level ACT intervention is a departure from previous interventions conducted with the Asian American population since it integrates smoking cessation with lung cancer screening education and actively addresses negative attitudes and beliefs toward NRT assessed at baseline during counseling sessions.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"158 ","pages":"Article 108102"},"PeriodicalIF":1.9000,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Randomized controlled trial of an Asian culture-tailored lung health intervention study for Chinese and Korean Americans: Study protocol\",\"authors\":\"Sun S. Kim ,&nbsp;Manan M. Nayak ,&nbsp;Ling Shi ,&nbsp;Hua Chen ,&nbsp;Sohyon Pak ,&nbsp;Joosun Shin ,&nbsp;Chi-Fu Yang ,&nbsp;Fang Lei ,&nbsp;Mary E. Cooley\",\"doi\":\"10.1016/j.cct.2025.108102\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Asian Americans are less likely to receive smoking cessation advice and more likely to be diagnosed with lung cancer at a distant stage of the disease than the general U.S. population. The primary outcomes of this study are the uptake of a lung cancer screening (LCS) test and biochemically verified smoking cessation abstinence 6 months after baseline assessment among 128 Asian Americans. The secondary outcomes include self-reported 7-day point prevalence abstinence at 1, 3, and 6 months. Participants will be randomized to either an experimental or a control group. The experimental group will receive a deep-level Asian culturally tailored lung health (ACT) intervention consisting of eight smoking cessation counseling sessions, education about the LCS test, and family coaching. Participants in the control group will receive a surface-level ACT intervention that includes six smoking cessation counseling sessions. Both groups will have the option of having counseling sessions via either video or telephone calls, depending on their preference. Counselors in both groups will be matched with participants based on ethnicity and language. Additionally, all participants irrespective of group allocation will receive combined nicotine replacement therapy (NRT) products and educational materials about LCS decision-aids and NRT products. The deep-level ACT intervention is a departure from previous interventions conducted with the Asian American population since it integrates smoking cessation with lung cancer screening education and actively addresses negative attitudes and beliefs toward NRT assessed at baseline during counseling sessions.</div></div>\",\"PeriodicalId\":10636,\"journal\":{\"name\":\"Contemporary clinical trials\",\"volume\":\"158 \",\"pages\":\"Article 108102\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-10-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contemporary clinical trials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1551714425002964\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714425002964","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

与普通美国人相比,亚裔美国人接受戒烟建议的可能性较小,而且更有可能在肺癌的早期阶段被诊断出患有肺癌。本研究的主要结果是128名亚裔美国人在基线评估后6 个月接受肺癌筛查(LCS)测试和生化验证戒烟。次要结局包括自我报告的在1、3和6 个月的7天点流行禁欲。参与者将被随机分为实验组和对照组。实验组将接受深度的亚洲文化量身定制的肺部健康(ACT)干预,包括8次戒烟咨询会议、LCS测试教育和家庭指导。对照组的参与者将接受表面水平的ACT干预,包括六次戒烟咨询会议。两组都可以根据自己的喜好,选择通过视频或电话进行咨询。两组的咨询师将根据种族和语言与参与者进行匹配。此外,无论分组分配如何,所有参与者都将接受尼古丁替代疗法(NRT)产品和有关LCS决策辅助工具和NRT产品的教育材料。深层ACT干预不同于以往对亚裔美国人进行的干预,因为它将戒烟与肺癌筛查教育结合起来,并积极解决在咨询期间基线评估时对NRT的负面态度和信念。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Randomized controlled trial of an Asian culture-tailored lung health intervention study for Chinese and Korean Americans: Study protocol
Asian Americans are less likely to receive smoking cessation advice and more likely to be diagnosed with lung cancer at a distant stage of the disease than the general U.S. population. The primary outcomes of this study are the uptake of a lung cancer screening (LCS) test and biochemically verified smoking cessation abstinence 6 months after baseline assessment among 128 Asian Americans. The secondary outcomes include self-reported 7-day point prevalence abstinence at 1, 3, and 6 months. Participants will be randomized to either an experimental or a control group. The experimental group will receive a deep-level Asian culturally tailored lung health (ACT) intervention consisting of eight smoking cessation counseling sessions, education about the LCS test, and family coaching. Participants in the control group will receive a surface-level ACT intervention that includes six smoking cessation counseling sessions. Both groups will have the option of having counseling sessions via either video or telephone calls, depending on their preference. Counselors in both groups will be matched with participants based on ethnicity and language. Additionally, all participants irrespective of group allocation will receive combined nicotine replacement therapy (NRT) products and educational materials about LCS decision-aids and NRT products. The deep-level ACT intervention is a departure from previous interventions conducted with the Asian American population since it integrates smoking cessation with lung cancer screening education and actively addresses negative attitudes and beliefs toward NRT assessed at baseline during counseling sessions.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.70
自引率
4.50%
发文量
281
审稿时长
44 days
期刊介绍: Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信